IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage-Reference-Cited by-同舟云学术

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage

Published:2010-04 Issue:4 Volume:52 Page:550-559
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Tovar Victoria,Alsinet Clara,Villanueva Augusto,Hoshida Yujin,Chiang Derek Y.,Solé Manel,Thung Swan,Moyano Susana,Toffanin Sara,Mínguez Beatriz,Cabellos Laia,Peix Judit,Schwartz Myron,Mazzaferro Vincenzo,Bruix Jordi,Llovet Josep M.

Funder

Instituto de Salud Carlos III

Italian Association for Cancer Research

Italian National Ministry of Health

Instituto Carlos III

U.S. National Institute of Diabetes and Digestive and Kidney Diseases

Samuel Waxman Cancer Research Foundation

Spanish National Health Institute

Publisher

Elsevier BV

Subject

Hepatology

Reference35 articles.

1. Hepatocellular carcinoma;Llovet;Lancet,2003

2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

3. Genomics and signaling pathways in hepatocellular carcinoma;Villanueva;Semin Liver Dis,2007

4. Insulin and insulin-like growth factor signalling in neoplasia;Pollak;Nat Rev Cancer,2008

5. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis;Peruzzi;Mol Cell Biol,1999

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer;Future Oncology;2024-05-13

2. New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma;Drugs;2023-07-04

3. Sublethal necroptosis signaling promotes inflammation and liver cancer;Immunity;2023-07

4. Identification ofIGF2as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma;Molecular Cancer Therapeutics;2023-02-10

5. Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma;Current Oncology;2023-01-18